Flightpath Biosciences, Inc.
PrivateLast Round
Series A
Oct 23, 2024
Est. Valuation
$19M
Total Funding Raised
$8.25M
Company Overview
Flightpath Biosciences, Inc. is a clinical-stage biotechnology company that develops medications to treat rare and complex infectious diseases by pioneering a microbiome-sparing approach.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Government Contracts, Revenue Share
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Flightpath Biosciences, Inc. Comps
Public and private peers based on sector, stage, and business model.
Flightpath Biosciences, Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Oct 23, 2024 | ||||
| Seed | Mar 8, 2023 | ||||
| Accelerator | Feb 9, 2021 |
Flightpath Biosciences, Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Steven & Alexandra Cohen Foundation | Series A |
| Ann Arbor SPARK | Series A |
| Northern Michigan Angels | Series A |
| Michigan Rise | Series A, Seed |
| Bay Area Lyme Foundation | Series A |
| Michigan Economic Development Corporation | Seed |
| Red Cedar Ventures | Seed |
Flightpath Biosciences, Inc. Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Flightpath Biosciences, Inc.'s valuation, stock price, and market status.
